In a retrospective analysis of a high-risk DLBCL collective bearing MYC rearrangements as single, double or triple events (the latter in conjunction with BCL2 and/or BCL6 translocations), no benefit of R-CHOEP over R-CHOP was detected [29]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.